Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.010
+0.010 (1.00%)
At close: Jun 11, 2026, 4:00 PM EDT
1.040
+0.030 (2.97%)
After-hours: Jun 11, 2026, 7:12 PM EDT
Cocrystal Pharma Employees
Cocrystal Pharma had 10 employees as of December 31, 2025. The number of employees decreased by 1 or -9.09% compared to the previous year.
Employees
10
Change (1Y)
-1
Growth (1Y)
-9.09%
Revenue / Employee
$22,500
Profits / Employee
-$882,900
Market Cap
13.93M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 10 | -1 | -9.09% |
| Dec 31, 2024 | 11 | -1 | -8.33% |
| Dec 31, 2023 | 12 | 0 | - |
| Dec 31, 2022 | 12 | -1 | -7.69% |
| Dec 31, 2021 | 13 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Quince Therapeutics | 38 |
| BioLineRx | 24 |
| Jasper Therapeutics | 22 |
| OSR Holdings | 22 |
| IN8bio | 17 |
| Moleculin Biotech | 17 |
| CalciMedica | 16 |
| Cadrenal Therapeutics | 5 |
COCP News
- 8 days ago - Cocrystal co-CEOs Sam Lee and Jim Martin step down, James Sapirstein succeeds - TheFly
- 8 days ago - Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer - GlobeNewsWire
- 16 days ago - Cocrystal Pharma announces discovery of pan-viral inhibitors targeting viruses - TheFly
- 16 days ago - Cocrystal Pharma Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus and Influenza - GlobeNewsWire
- 27 days ago - Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 6 weeks ago - Cocrystal Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment of Norovirus Infection - GlobeNewsWire
- 7 weeks ago - Cocrystal Pharma files $150M mixed securities shelf - TheFly
- 2 months ago - Cocrystal Pharma receives FDA Fast Track designation for CDI-988 - TheFly